- €255.08m
- €120.05m
- €289.61m
- 93
- 56
- 77
- 90
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 260 | 173 | 161 | 215 | 290 |
Cost of Revenue | |||||
Gross Profit | 103 | 64.1 | 50.9 | 68.7 | 93.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 243 | 193 | 169 | 213 | 274 |
Operating Profit | 16.3 | -19.8 | -7.88 | 2.57 | 15.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 15.4 | -20.7 | -8.59 | 1.86 | 15.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11 | -18.3 | -6.16 | 0.993 | 9.58 |
Net Income Before Extraordinary Items | |||||
Net Income | 11 | -18.3 | -6.16 | 0.993 | 9.58 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11 | -18.3 | -6.16 | 0.993 | 9.58 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.721 | -1.15 | -0.404 | -0.043 | 0.64 |
Dividends per Share |